prognosticul cancerului de col uterin în contextul unor - Gr.T. Popa
prognosticul cancerului de col uterin în contextul unor - Gr.T. Popa
prognosticul cancerului de col uterin în contextul unor - Gr.T. Popa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
36. Irimie A, Nicula FAl, Şuteu O, et al. Programul <strong>de</strong> prevenţie şi<br />
control <strong>în</strong> patologia on<strong>col</strong>ogică. Ed Medicală Universitară “Iuliu<br />
Haţieganu”, Cluj Napoca, 2005; 5-9.<br />
37. Irwin M, Daniels M, Bloom ET. Life events <strong>de</strong>pressive<br />
symptoms, and immune function. Am J Psychiatriy, 1987; 144: 437-<br />
441.<br />
38. Kainz C, Speiser P, Wanner C, et al. Prognostic value of tumour<br />
microvessel <strong>de</strong>nsity in cancer of the <strong>uterin</strong>e cervix stage IB to IIB.<br />
Anticancer Res, 1995; 15(4):1549-1551.<br />
39. Kedzia W, Schmidt M, Frankowski A, et al.<br />
Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and<br />
Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.<br />
Folia Histochemica et Cytobiologica, 2002; 40(1): 37-41.<br />
40. Kim SH, Choi BI, Han JK, et al. Preoperative staging of <strong>uterin</strong>e<br />
cervical carcinoma: Comparison of CT and MRI in 99 patients. J<br />
Comput Assist Tomogr, 1993; 17: 63.<br />
41. Lanciano RM, Pajak TF, Martz K, et al. The influence of<br />
treatment time on outcome for squamous cell cancer of the <strong>uterin</strong>e<br />
cervix treated with radiation: A patterns-of-care study. Int J Radiot<br />
On<strong>col</strong> Biol Phys, 1993; 25: 391-397.<br />
42. Lansky S, List M, Herman C, et al. Absence of major <strong>de</strong>pressive<br />
disor<strong>de</strong>rs in female cancer patients. J Clin On<strong>col</strong>, 1985; 3: 1553-<br />
1560.<br />
43. Mantel N. Evaluation of survival data and two rank or<strong>de</strong>r<br />
statistics arising in its consi<strong>de</strong>ration. Cancer Chemother Rep, 1966;<br />
50: 163-170.<br />
44. Monk BJ, Tian C, Rose PG, et al. Which clinical/pathologic<br />
factors matter in the era of chemoradiation as treatment for locally<br />
advanced cervical carcinoma? Analysis of two Gyne<strong>col</strong>ogic<br />
On<strong>col</strong>ogy <strong>Gr</strong>oup (GOG) trials. Gyne<strong>col</strong> On<strong>col</strong>, 2007; 105(2): 427-<br />
433.<br />
45. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and<br />
human papillomavirus in cervical cancer: the IARC multicentric<br />
case-control study. Lancet, 2002; 359(9312): 1093-1101.<br />
46. Nakano T, Oka K. Differential values of Ki-67 in<strong>de</strong>x and mitotic<br />
in<strong>de</strong>x of proliferating cell population. An assessment of cell cycle<br />
and prognosis in radiation therapy for cervical cancer. Cancer, 1993;<br />
72(8): 2401-2408.<br />
56